InvestorsHub Logo
Followers 32
Posts 1683
Boards Moderated 0
Alias Born 01/11/2014

Re: gr8db8 post# 1528

Saturday, 10/21/2017 2:34:44 PM

Saturday, October 21, 2017 2:34:44 PM

Post# of 2099
I agree, the drug holds promise and this is to its dual effect on tumor vasculature and immune system stimulation. I also agree with Oren that combination with pd1 inhibitors represent a compelling opportunity in all cancer types, as pd1 inihibitors break the brakes that the tumor generates to the immune system , whereas VB 111 both makes it more difficult for the tumor to grow and gives more gas to the immune system to destroy it. Their MOA's are evidently complementary.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News